NYTIMES  |  Health

Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

拥有30年垄断的药物成为各州推动抑制价格的目标

Enbrel, a once-a-week injection used to treat a variety of autoimmune conditions, first arrived on the market nearly 30 years ago.

Enbrel, a once-a-week injection used to treat a variety of autoimmune conditions, first arrived on the market nearly 30 years ago.

2025-10-23  1134  困难
字体大小

--:--
--:--

此音频仅限会员使用成为会员

Those dynamics have recently made Enbrel a target of federal and state efforts to lower drug prices.

请登录后继续阅读完整文章

还没有账号?立即注册

成为会员后您将享受无限制的阅读体验,并可使用更多功能,了解更多


免责声明:本文来自网络公开资料,仅供学习交流,其观点和倾向不代表本站立场。